Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.
2.

[Ghostwriting].

Haug C.

Tidsskr Nor Laegeforen. 2008 May 1;128(9):1039. Norwegian. No abstract available.

3.

[Knowledge on feet of clay].

Dahlqvist R.

Lakartidningen. 2008 May 7-13;105(19):1405-6. Swedish. No abstract available.

PMID:
18574980
4.

[The journals must honestly tell who is doing the job].

Bergström R.

Lakartidningen. 2008 May 7-13;105(19):1406-7. Swedish. No abstract available.

PMID:
18574981
5.

Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.

Mansi BA, Clark J, David FS, Gesell TM, Glasser S, Gonzalez J, Haller DG, Laine C, Miller CL, Mooney LA, Zecevic M.

Mayo Clin Proc. 2012 May;87(5):424-9. doi: 10.1016/j.mayocp.2012.02.009. No abstract available.

6.

"No free lunch" meets the academic journals.

Hughes JA.

Acad Emerg Med. 2003 Jun;10(6):691-2. No abstract available.

7.

The sins of ghostwriting.

Somberg JC.

Am J Ther. 2008 Jul-Aug;15(4):297-8. doi: 10.1097/MJT.0b013e318180f387. No abstract available.

PMID:
18645328
8.

How pharmaceutical industry funding affects trial outcomes: causal structures and responses.

Sismondo S.

Soc Sci Med. 2008 May;66(9):1909-14. doi: 10.1016/j.socscimed.2008.01.010. Epub 2008 Mar 4.

PMID:
18299169
9.

Reject influence of pharmaceutical industry.

McPartland JM.

J Am Osteopath Assoc. 2009 Dec;109(12):655. No abstract available.

PMID:
20023226
10.

Publication ethics and the ghost management of medical publication.

Sismondo S, Doucet M.

Bioethics. 2010 Jul;24(6):273-83. doi: 10.1111/j.1467-8519.2008.01702.x. Epub 2009 Feb 16.

PMID:
19222451
11.

Ethical issues in the relationships involving medicine and industry.

Thomas PS, Tan KS, Yates DH.

Intern Med J. 2005 Dec;35(12):732. No abstract available.

PMID:
16313554
12.

Review article: gastroenterology and the pharmaceutical industry.

Rakatansky H.

Aliment Pharmacol Ther. 2002 Nov;16(11):1859-66. Review.

13.

Ghost- and guest-authored pharmaceutical industry-sponsored studies: abuse of academic integrity, the peer review system, and public trust.

Flaherty DK.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):1081-3. doi: 10.1345/aph.1R691. Epub 2013 Jun 26. Review.

PMID:
23585648
14.

Biased articles.

Friedman JH.

Med Health R I. 2009 Mar;92(3):70. No abstract available.

PMID:
19385378
15.
16.

Conflict of interest in peer-reviewed medical journals: the World Association of Medical Editors (WAME) position on a challenging problem.

Ferris LE, Fletcher RH.

Neurosurgery. 2010 Apr;66(4):629-30. doi: 10.1227/01.neu.0000369904.38343.e4. No abstract available.

PMID:
20305486
17.

Academic Emergency Medicine can print pharmaceutical advertising while not compromising its mission or its integrity.

Gaddis GM, Olson JE, Wright DW.

Acad Emerg Med. 2009 Oct;16(10):978-81. doi: 10.1111/j.1553-2712.2009.00534.x. No abstract available.

18.

College activities and the ethics of advertising.

Ryan C, Walter G, Robertson M.

Australas Psychiatry. 2010 Apr;18(2):101-5. doi: 10.3109/10398561003665577.

PMID:
20307152
19.

Medical ethics, research and the pharmaceutical industry.

Abud-Mendoza C.

Reumatol Clin. 2012 Sep-Oct;8(5):233-5. Epub 2012 May 17. No abstract available.

20.

What is your opinion on the "medical ethics of medical journal editors"?

Phaosavasdi S, Taneepanichskul S, Tannirandorn Y, Thamkhantho M, Prugsapong C, Phupong V, Karnjanapitak A.

J Med Assoc Thai. 2005 Aug;88(8):1163-4. No abstract available.

PMID:
16404851

Supplemental Content

Support Center